Slight organic sales growth and a strong ORfA recovery in H1 2026 were achieved despite a challenging macroeconomic and geopolitical environment. The Rebound plan is delivering early results, with full-year guidance confirmed and a focus on cost savings and innovation.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.